Animal studies have raised concerns about fetal development risks
It really depends on your goals, how your body absorbs nutrients, and what kind of support you need long-term
GLP-1RAs linked to fewer major limb events The meta-analysis of 12 studies found that GLP-1RA use was associated with a 27% lower risk of major limb events in patients with type 2 diabetes and PAD compared with placebo, other glucose-lowering therapies, including SGLT-2 inhibitors and DPP-4 inhibitors, or GLP-1RA non-use
References Siegel RL, Miller KD, Jemal A
BMI over 27 with a weight-related condition: This includes conditions like high blood pressure, type 2 diabetes, or high cholesterol
Antagonistic effects of oxidized low density lipoprotein and -tocopherol on CD36 scavenger receptor expression in monocytes: involvement of protein kinase B and peroxisome proliferator-activated receptor- *